{"meta":{"query_hash":"dc97dff233d3","filters":{"venue":"CPT Pharmacometrics & Systems Pharmacology"},"cohort_total":48,"direct_labels_cover":0,"predictions_cover":48,"exported":48,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dc97dff233d3","api":"https://metacan.xera.ac/api/v1/cohort?venue=CPT+Pharmacometrics+%26+Systems+Pharmacology"},"results":[{"id":"W2023850571","doi":"10.1038/psp.2013.22","title":"Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis","year":2013,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Pharmacokinetics; Clinical trial; Placebo; Population; Pharmacology; Plaque psoriasis; Internal medicine; Covariate; Dosing; Dermatology; Rheumatoid arthritis; Statistics; Pathology; Mathematics","score_opus":0.03613601634449804,"score_gpt":0.30933716649492865,"score_spread":0.2732011501504306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023850571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590135,0.033575274,0.000018396388,0.00022554162,0.0039965576,0.0024440964,0.0005626555,0.000058529422,0.00010544929],"genre_scores_gemma":[0.99096906,0.0072244178,0.00004068514,0.00012993453,0.00029048754,0.0007893198,0.00017511807,0.000052259154,0.00032873458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936917,0.0032908132,0.001299044,0.00069174025,0.0001831698,0.000843521],"domain_scores_gemma":[0.9965354,0.0019309421,0.0006377256,0.00047899553,0.00027442267,0.00014250126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013300906,0.0006222661,0.0012022525,0.0016159636,0.00017668647,0.0000363636,0.000620508,0.00041741884,0.0008340318],"category_scores_gemma":[0.00006185883,0.0004684704,0.00022876401,0.0019287491,0.00047976227,0.0002824064,0.0000935111,0.00033577933,0.00009087227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030623209,0.0041644983,0.009222901,0.0002082471,0.0009819536,0.00010549195,0.0024235433,0.00012170014,0.91505396,0.000050615457,0.0032491093,0.061355654],"study_design_scores_gemma":[0.03538133,0.006254511,0.0183979,0.000055685592,0.0015590144,0.00027581074,0.0010707224,0.00048299658,0.8324315,0.00002014752,0.103361934,0.0007084476],"about_ca_topic_score_codex":0.0009353866,"about_ca_topic_score_gemma":0.000016496728,"teacher_disagreement_score":0.100112826,"about_ca_system_score_codex":0.0003284515,"about_ca_system_score_gemma":0.00023785522,"threshold_uncertainty_score":0.9997767},"labels":[],"label_agreement":null},{"id":"W2139500170","doi":"10.1038/psp.2014.45","title":"Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development","year":2014,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Physiologically based pharmacokinetic modelling; Computer science; Pharmacokinetics; Drug development; Modeling and simulation; Management science; Drug; Pharmacology; Medicine; Simulation; Engineering","score_opus":0.07256514769696606,"score_gpt":0.385557649965583,"score_spread":0.31299250226861697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139500170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771815,0.008579863,0.008597092,0.00092794356,0.0016964341,0.0014154232,0.0000055590895,0.00018173105,0.0014144785],"genre_scores_gemma":[0.9928591,0.002105039,0.0006938927,0.0030278047,0.0009532264,0.00019531164,0.000020229352,0.000048213955,0.00009714227],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9962761,0.0006409708,0.0010123103,0.00075000065,0.0005235251,0.00079711777],"domain_scores_gemma":[0.9967366,0.0020261032,0.00029871642,0.00015866068,0.0002679194,0.0005119922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019632513,0.0004440884,0.0008516155,0.0012060085,0.00023375958,0.00005386341,0.00023174463,0.00014842203,0.00020375507],"category_scores_gemma":[0.00033747352,0.0003879168,0.00009672815,0.002091498,0.00007556541,0.00021348198,0.00018791054,0.0007886632,0.00006666965],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021282902,0.0020773928,0.07463237,0.0032096058,0.000431885,0.00019006184,0.00048910023,0.83060616,0.040404893,0.0000541897,0.002597772,0.04317829],"study_design_scores_gemma":[0.00765743,0.00013604945,0.0060228673,0.000033198303,0.00050362287,0.000017697372,0.00003013189,0.93086874,0.0014447382,0.000011023235,0.052866053,0.000408467],"about_ca_topic_score_codex":0.000027539998,"about_ca_topic_score_gemma":8.460572e-7,"teacher_disagreement_score":0.10026257,"about_ca_system_score_codex":0.00023322084,"about_ca_system_score_gemma":0.00012523305,"threshold_uncertainty_score":0.99985725},"labels":[],"label_agreement":null},{"id":"W2292177683","doi":"10.1002/psp4.12069","title":"Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction","year":2016,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Université de Montréal; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Mitacs; McGill University; Novartis; Pfizer","keywords":"Forensic engineering; Biology; Engineering","score_opus":0.05893023120036727,"score_gpt":0.37050854256729765,"score_spread":0.31157831136693037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292177683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92690593,0.02305988,0.009931896,0.018167084,0.009741496,0.0037203543,0.000100729805,0.0002588412,0.008113786],"genre_scores_gemma":[0.98068804,0.011501197,0.00014205454,0.0023906473,0.0039350674,0.00039543,0.000013199174,0.00005259771,0.00088178046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521977,0.001132735,0.0011913802,0.0008114873,0.00076566654,0.0008789346],"domain_scores_gemma":[0.99131364,0.006949065,0.00072696473,0.00039927228,0.00032242882,0.0002886484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034452712,0.0005686554,0.001219027,0.00097081723,0.00095276476,0.000086146894,0.0006143374,0.00016236599,0.00029290043],"category_scores_gemma":[0.00089996087,0.0002732532,0.00026806587,0.0028086668,0.0013547583,0.00038030927,0.00048379955,0.0020092227,0.00004760234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031065787,0.000459934,0.323636,0.0011306346,0.008249943,0.00023476282,0.005300053,0.000024967867,0.028552597,0.0030950003,0.014594717,0.6116148],"study_design_scores_gemma":[0.10560327,0.002127658,0.027368665,0.00083100464,0.010627638,0.0037453072,0.010146141,0.0033342943,0.026479676,0.0012509115,0.80645794,0.0020274816],"about_ca_topic_score_codex":0.00034359936,"about_ca_topic_score_gemma":0.0000014095622,"teacher_disagreement_score":0.79186326,"about_ca_system_score_codex":0.00033945372,"about_ca_system_score_gemma":0.0001029083,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W2601521858","doi":"10.1002/psp4.12182","title":"Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Eli Lilly and Company; Galderma; Astellas Pharma; Mylan; UCB Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Meiji Seika Pharma","keywords":"Tofacitinib; Janus kinase inhibitor; Plaque psoriasis; Medicine; Psoriasis; Potency; Body weight; Internal medicine; Psoriasis Area and Severity Index; Population; Pharmacology; Body surface area; Janus kinase; Clinical trial; Dermatology; Chemistry","score_opus":0.0632394518170323,"score_gpt":0.38185053162312693,"score_spread":0.3186110798060946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601521858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345786,0.008712418,0.00006416512,0.0002355469,0.0044966247,0.0023395235,0.00050877774,0.000049618124,0.00013545758],"genre_scores_gemma":[0.9972733,0.00097305287,0.00019723966,0.00013581853,0.0002625383,0.0008314471,0.00010366634,0.000036102876,0.00018680346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956334,0.0017639745,0.001047077,0.00070147216,0.00013473135,0.0007193291],"domain_scores_gemma":[0.9961444,0.0018494675,0.0009881449,0.00059071544,0.00032558947,0.000101648264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043451143,0.000438356,0.0010758536,0.00065352715,0.0007770499,0.00008681908,0.00093029597,0.0003745269,0.00008951327],"category_scores_gemma":[0.00059916236,0.00033668763,0.00018086436,0.0004868265,0.00080987945,0.00047523185,0.00029415503,0.00042251786,0.000017941691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067555755,0.0009873749,0.054135356,0.00047981806,0.0012753514,0.00005841937,0.0011115965,0.000629386,0.91111887,0.0013122591,0.0010587896,0.021077234],"study_design_scores_gemma":[0.17298742,0.0022623304,0.123368256,0.00025061873,0.0039056153,0.00032596115,0.0006000001,0.007524984,0.6570754,0.00037408224,0.029548908,0.0017764458],"about_ca_topic_score_codex":0.00080871204,"about_ca_topic_score_gemma":0.000016502176,"teacher_disagreement_score":0.25404346,"about_ca_system_score_codex":0.00011432676,"about_ca_system_score_gemma":0.00016763604,"threshold_uncertainty_score":0.9999085},"labels":[],"label_agreement":null},{"id":"W2617283416","doi":"10.1002/psp4.12200","title":"A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; ViiV Healthcare","keywords":"Darunavir; Efavirenz; Drug; Emtricitabine; Medicine; Drug resistance; Population; Lymph node; HIV drug resistance; Human immunodeficiency virus (HIV); Intensive care medicine; Pharmacology; Oncology; Internal medicine; Antiretroviral therapy; Virology; Biology; Viral load; Genetics","score_opus":0.024856169110513134,"score_gpt":0.31447852652786945,"score_spread":0.2896223574173563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617283416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834676,0.006025296,0.0022159754,0.0024545577,0.000642672,0.0016397787,0.0005512975,0.00007970836,0.0029231415],"genre_scores_gemma":[0.9973364,0.00035757193,0.00014939123,0.00020874696,0.00010438206,0.0003811311,0.00006150728,0.00002509622,0.0013758031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755675,0.000538046,0.0005678765,0.00049827184,0.00016650859,0.0006725695],"domain_scores_gemma":[0.9981912,0.00060193456,0.00033377222,0.00051473884,0.00018079327,0.0001775789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010825695,0.00030334305,0.00058691215,0.00044013438,0.00072062993,0.000091134345,0.0009331745,0.00022048628,0.00036818194],"category_scores_gemma":[0.00023290364,0.00020220816,0.00011234249,0.00029870286,0.00051384565,0.00017226169,0.0005118732,0.00043091335,0.00070003606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062868913,0.000786241,0.024068646,0.00017398805,0.001044422,0.000048660444,0.00065809896,0.0010324334,0.9372682,0.00190412,0.02877326,0.0036132468],"study_design_scores_gemma":[0.032717798,0.0011586602,0.030761033,0.00017716181,0.0023812049,0.0012878382,0.0014742087,0.12546554,0.6442534,0.0020315766,0.15647058,0.0018209949],"about_ca_topic_score_codex":0.000059432907,"about_ca_topic_score_gemma":0.0000018792678,"teacher_disagreement_score":0.2930148,"about_ca_system_score_codex":0.00008724236,"about_ca_system_score_gemma":0.000110569155,"threshold_uncertainty_score":0.8997781},"labels":[],"label_agreement":null},{"id":"W2748594989","doi":"10.1002/psp4.12245","title":"Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Drug development; Process development; Biopharmaceutical; Drug discovery; Computational biology; Monoclonal antibody; Clinical efficacy; Medicine; Drug; Computer science; Pharmacology; Bioinformatics; Biology; Engineering; Immunology; Antibody; Internal medicine; Biotechnology; Process management","score_opus":0.07858451370996541,"score_gpt":0.3975746733348072,"score_spread":0.3189901596248418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748594989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913007,0.0032983043,0.0030898664,0.0000128222055,0.001161701,0.0009012777,0.000081880346,0.000015265085,0.00013818697],"genre_scores_gemma":[0.9989715,0.00020106013,0.00027070977,0.00008541521,0.00016306138,0.00015870332,0.000012390336,0.00003650484,0.00010064428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783593,0.00022166967,0.0007769042,0.0005422879,0.0002753169,0.00034786228],"domain_scores_gemma":[0.9981709,0.00007635958,0.00072132924,0.00051483244,0.00027421885,0.00024234786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005450718,0.00029760168,0.00050739705,0.0004146047,0.00043975565,0.00006951289,0.00044898363,0.00014708683,0.000020326383],"category_scores_gemma":[0.00008775531,0.0002761624,0.000099652505,0.00021596965,0.00023070483,0.000028539365,0.0004928962,0.00016088478,0.0000016247698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005911905,0.0023705126,0.020581616,0.00061925733,0.0006258636,0.000270436,0.000333727,0.0055827936,0.96452266,0.0000098923365,0.0011430451,0.003349018],"study_design_scores_gemma":[0.018446617,0.0017851198,0.0015685223,0.00007201069,0.00072376133,0.00050706195,0.0017433033,0.05518758,0.91307604,0.0000073927963,0.0059444946,0.00093809824],"about_ca_topic_score_codex":0.00012738537,"about_ca_topic_score_gemma":0.000008896832,"teacher_disagreement_score":0.05144661,"about_ca_system_score_codex":0.00003153693,"about_ca_system_score_gemma":0.00025439257,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W2766248288","doi":"10.1002/psp4.12252","title":"Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Thrasher Research Fund","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Plasma concentration; Regimen; Confidence interval; Area under the curve; Minimum inhibitory concentration; Population; Pharmacology; Medicine; Chemistry; Internal medicine; Antibiotics","score_opus":0.06842512572379734,"score_gpt":0.3693630458961107,"score_spread":0.30093792017231336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766248288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630797,0.00018644596,0.0008188251,0.00016160871,0.0011072666,0.00091143395,0.000074257485,0.00005189568,0.00038030866],"genre_scores_gemma":[0.99729276,0.00019603097,0.0016912686,0.00037366545,0.00021225434,0.00014226242,0.000013900917,0.000037913,0.000039963616],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971848,0.0002325625,0.001204143,0.0005119834,0.00037261337,0.00049388845],"domain_scores_gemma":[0.99781287,0.00022216563,0.0007943181,0.00035245938,0.0004570689,0.00036111902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000852577,0.0003375606,0.0010393504,0.0012652652,0.0002692482,0.00002381924,0.0004086191,0.00021697796,0.000045012657],"category_scores_gemma":[0.00020898094,0.00029463114,0.00011624933,0.00055441126,0.00030999113,0.00019855086,0.00016488596,0.00046255544,0.0000062029794],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042637013,0.000981042,0.009230382,0.00079112354,0.0001823679,0.00004731747,0.00032674556,0.008569769,0.9743686,0.000024298253,0.00006200402,0.004989984],"study_design_scores_gemma":[0.011263501,0.00048661188,0.018197874,0.00016359582,0.000319094,0.000042430274,0.00009663851,0.53380895,0.4344124,0.0000059259232,0.00089536986,0.00030761244],"about_ca_topic_score_codex":0.000035287663,"about_ca_topic_score_gemma":0.0000029738524,"teacher_disagreement_score":0.5399562,"about_ca_system_score_codex":0.000120166565,"about_ca_system_score_gemma":0.00047990147,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2882991814","doi":"10.1002/psp4.12338","title":"Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on<scp>ECMO</scp>","year":2018,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Blackberry (Canada)","funders":"National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; Biomedical Advanced Research and Development Authority; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; Thrasher Research Fund","keywords":"Life support; Dosing; Extracorporeal; Pharmacokinetics; Fluconazole; Extracorporeal membrane oxygenation; Medicine; Pharmacology; Intensive care medicine; Anesthesia; Antifungal; Internal medicine","score_opus":0.04443819642409358,"score_gpt":0.3241481951567232,"score_spread":0.27970999873262964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2882991814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716896,0.00045657292,0.0015739967,0.00047109748,0.0038058977,0.004586601,0.00023450481,0.00039795597,0.016783776],"genre_scores_gemma":[0.971765,0.00023863406,0.0009552683,0.021134151,0.0043004258,0.00025333354,0.00027937212,0.00023593544,0.0008379243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99196947,0.00065276696,0.0019012003,0.0020211996,0.0012867076,0.002168678],"domain_scores_gemma":[0.9945926,0.0013155807,0.00066620286,0.00074961624,0.00059091486,0.0020850638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015953168,0.0012213117,0.0018415276,0.0041284654,0.00033538844,0.00013832605,0.001131502,0.00047464695,0.00060804887],"category_scores_gemma":[0.00057926326,0.0011061216,0.00043359568,0.0052048163,0.00045641512,0.00014840059,0.00032748107,0.0017004039,0.0011984983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026339544,0.012521015,0.03282555,0.0007122982,0.0011285164,0.0006608427,0.00037757837,0.012395615,0.6917913,0.0001825639,0.2316105,0.013160262],"study_design_scores_gemma":[0.05921873,0.013079656,0.22115208,0.00047717337,0.0024324858,0.00080864463,0.0001392142,0.28784978,0.31927904,0.000019491465,0.09339032,0.0021533603],"about_ca_topic_score_codex":0.000048910635,"about_ca_topic_score_gemma":3.4711957e-7,"teacher_disagreement_score":0.37251225,"about_ca_system_score_codex":0.00048039432,"about_ca_system_score_gemma":0.00043469714,"threshold_uncertainty_score":0.9995792},"labels":[],"label_agreement":null},{"id":"W2919263543","doi":"10.1002/psp4.12398","title":"Physiologically‐Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter–Mediated Interactions Between Metformin and Cimetidine","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Cimetidine; Metformin; Pharmacokinetics; Pharmacology; Transporter; Chemistry; Drug; In vitro; Medicine; Insulin; Internal medicine; Biochemistry","score_opus":0.07485222278912905,"score_gpt":0.3512747445962903,"score_spread":0.27642252180716126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919263543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912638,0.0015060317,0.20252208,0.00013108217,0.0011123898,0.0022395926,0.0009885235,0.00011612289,0.000120378456],"genre_scores_gemma":[0.9955003,0.00047845236,0.0019026292,0.0001522601,0.00024692484,0.00028006628,0.001160935,0.00005127505,0.00022714479],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968892,0.0001708487,0.0012756814,0.0006918737,0.00044641265,0.0005259906],"domain_scores_gemma":[0.99735886,0.00095607084,0.00052125164,0.00021137067,0.0006135972,0.00033887636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095201447,0.0004058668,0.0015641942,0.0027226952,0.00010782046,0.000015680738,0.00020782503,0.00018505228,0.00034896043],"category_scores_gemma":[0.000043344135,0.0003444607,0.00051429315,0.0037198,0.000106185995,0.00019015263,0.000021754264,0.0004387015,0.00000902541],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016910752,0.00050877366,0.031246338,0.0013182933,0.005094386,0.000018514087,0.00015777808,0.034645543,0.9246071,0.00006473492,0.00014359073,0.0005039031],"study_design_scores_gemma":[0.012802402,0.0012374196,0.007823478,0.00012806359,0.015496341,0.000012231352,0.00021330558,0.8584997,0.09979717,0.000019483508,0.0035674947,0.00040288907],"about_ca_topic_score_codex":0.000028720204,"about_ca_topic_score_gemma":9.797091e-7,"teacher_disagreement_score":0.8248099,"about_ca_system_score_codex":0.00012050782,"about_ca_system_score_gemma":0.00011505227,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W2945839580","doi":"10.1002/psp4.12414","title":"Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacokinetics; Cerebrospinal fluid; Dosing; Fluconazole; Medicine; Physiologically based pharmacokinetic modelling; Plasma concentration; Pharmacology; Internal medicine; Antifungal","score_opus":0.05298117718930536,"score_gpt":0.3324642961910152,"score_spread":0.27948311900170986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945839580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98759377,0.008199578,0.0010978776,0.000048849368,0.0011164426,0.0014791646,0.00021501124,0.00007867756,0.00017064018],"genre_scores_gemma":[0.9973056,0.0010301552,0.00077107566,0.0004080501,0.00029806036,0.00003408966,0.000055817378,0.000049045375,0.00004813195],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99681485,0.0002758789,0.00095823925,0.000876278,0.0004676149,0.00060714054],"domain_scores_gemma":[0.99793965,0.0006510969,0.00037335986,0.00031117146,0.00031853357,0.00040617943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053612306,0.00045020707,0.0012364091,0.0006374132,0.00012532722,0.000040097366,0.00024059175,0.000234425,0.0004218467],"category_scores_gemma":[0.0000961236,0.0003976025,0.00018321691,0.0007735715,0.00026574158,0.00020412078,0.0002034666,0.00047469465,0.000012884526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016065395,0.00022363616,0.18837625,0.0011374182,0.0003534793,0.000027100212,0.00008658429,0.002271277,0.8046696,0.00000853455,0.00007396124,0.0011656191],"study_design_scores_gemma":[0.011561145,0.0005774121,0.055336382,0.00029882533,0.0012005118,0.00005333534,0.000111612,0.8586639,0.071393706,0.000020569474,0.00027626773,0.00050634413],"about_ca_topic_score_codex":0.00016853929,"about_ca_topic_score_gemma":7.003381e-7,"teacher_disagreement_score":0.8563926,"about_ca_system_score_codex":0.00013100292,"about_ca_system_score_gemma":0.00017290647,"threshold_uncertainty_score":0.9998476},"labels":[],"label_agreement":null},{"id":"W2963315585","doi":"10.1002/psp4.12456","title":"Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients","year":2019,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Physiologically based pharmacokinetic modelling; Allometry; Pharmacokinetics; Population; Medicine; Pharmacology; Biology; Ecology","score_opus":0.07103963999053865,"score_gpt":0.36196636542348953,"score_spread":0.2909267254329509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963315585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96750283,0.013397965,0.0032065897,0.000728735,0.0069431616,0.007214433,0.00021192187,0.00015223489,0.00064212957],"genre_scores_gemma":[0.9887451,0.006836428,0.00027409018,0.0020100705,0.0011381855,0.00071925984,0.00009561939,0.00009542118,0.000085838605],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99452066,0.0004647609,0.0018928207,0.00092908234,0.0010369857,0.0011556799],"domain_scores_gemma":[0.99359417,0.0037891585,0.00086087285,0.0003772472,0.0009895434,0.00038901783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018892438,0.0006304828,0.0013748449,0.002300772,0.00021592391,0.00005065543,0.0007258602,0.00027786847,0.00036801034],"category_scores_gemma":[0.00058922323,0.00047486267,0.00044394255,0.006464056,0.00013387996,0.0002574872,0.00026804273,0.0011389643,0.000050195973],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010242893,0.005939955,0.49776903,0.0063263793,0.001666732,0.00003481251,0.0002562594,0.36838233,0.08564991,0.000060689606,0.0072583896,0.016412629],"study_design_scores_gemma":[0.027990548,0.0012229828,0.019516906,0.000069454356,0.0026259155,0.000009175457,0.0000624719,0.91191274,0.00466469,0.000008474307,0.03146239,0.00045423652],"about_ca_topic_score_codex":0.000038971262,"about_ca_topic_score_gemma":2.2345544e-7,"teacher_disagreement_score":0.5435304,"about_ca_system_score_codex":0.0003662222,"about_ca_system_score_gemma":0.0001927277,"threshold_uncertainty_score":0.9997703},"labels":[],"label_agreement":null},{"id":"W2982361299","doi":"10.1002/psp4.12473","title":"Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences","year":2019,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"Horizon 2020 Framework Programme","keywords":"Open science; Open source; Computer science; Pharmaceutical sciences; Management science; Medicine; Pharmacology; Engineering; Mathematics","score_opus":0.615142784337664,"score_gpt":0.6194145034598243,"score_spread":0.004271719122160289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982361299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00337382,0.8415359,0.0013687505,0.00033160386,0.008043477,0.090247825,0.00019200318,0.00018031079,0.054726284],"genre_scores_gemma":[0.10995617,0.8645994,0.00079447107,0.00340075,0.0013583492,0.011229273,0.00054792856,0.0005223857,0.007591284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809998,0.007302217,0.0032309582,0.003639027,0.001972022,0.0028559545],"domain_scores_gemma":[0.99130654,0.002600876,0.0014017561,0.0015660614,0.001009493,0.00211526],"candidate_categories":["metaresearch","metaepi_narrow","bibliometrics","sts","scholarly_communication","open_science","research_integrity"],"consensus_categories":["metaepi_narrow","open_science"],"category_scores_codex":[0.037581056,0.0015298999,0.0069802706,0.010412446,0.0022045006,0.019778512,0.05571054,0.0006712314,0.00032090285],"category_scores_gemma":[0.00054426113,0.0013113278,0.00021444452,0.021481972,0.0012466665,0.008899117,0.11173228,0.004011214,0.00022235863],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019268878,0.0115386285,0.0010051368,0.10133761,0.003295946,0.00024543153,0.001016175,0.27961138,0.0007815404,0.0014377134,0.032389224,0.5654143],"study_design_scores_gemma":[0.0070515885,0.00064124126,0.0000073164633,0.002626896,0.0020262112,0.00006123933,0.00034395972,0.44166687,0.000012807231,0.00000841033,0.5445702,0.0009832653],"about_ca_topic_score_codex":0.0039698402,"about_ca_topic_score_gemma":0.000008157846,"teacher_disagreement_score":0.5644311,"about_ca_system_score_codex":0.001968367,"about_ca_system_score_gemma":0.0050611417,"threshold_uncertainty_score":0.99974495},"labels":[],"label_agreement":null},{"id":"W3119901445","doi":"10.1002/psp4.12577","title":"Model‐Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Physiologically based pharmacokinetic modelling; Dapagliflozin; Pharmacokinetics; Dosing; Pharmacology; Context (archaeology); Medicine; Drug; Internal medicine; Endocrinology; Biology","score_opus":0.056117851728890875,"score_gpt":0.3404270299676117,"score_spread":0.2843091782387208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119901445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594117,0.011157648,0.008935757,0.0015651442,0.006268165,0.0056764334,0.00025599226,0.00061953714,0.006109629],"genre_scores_gemma":[0.9783994,0.0016046244,0.005006447,0.0021719937,0.0011760278,0.0015463473,0.00076065195,0.00009161927,0.009242879],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743056,0.00010052425,0.00066254154,0.00061508734,0.00044856628,0.0007427236],"domain_scores_gemma":[0.998278,0.00036057728,0.00037099654,0.00012705538,0.000492757,0.0003705775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005544448,0.00040402674,0.00068854657,0.0011942617,0.00026195528,0.00008142078,0.00017709895,0.00017076785,0.00015774387],"category_scores_gemma":[0.0001325336,0.0004042279,0.00014910728,0.0028714908,0.000037899204,0.00022533584,0.00015733972,0.000265234,0.000059044654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004865615,0.0018377518,0.035812348,0.0031678604,0.0020093254,0.00010880478,0.00030928425,0.001132043,0.319358,0.00027748916,0.6146953,0.020805204],"study_design_scores_gemma":[0.0410986,0.0014612918,0.00079470896,0.00009944708,0.007004127,0.00028084454,0.0006301939,0.29800633,0.26982787,0.000052341446,0.37901855,0.0017257215],"about_ca_topic_score_codex":0.00001244706,"about_ca_topic_score_gemma":0.0000048732577,"teacher_disagreement_score":0.29687428,"about_ca_system_score_codex":0.0008920716,"about_ca_system_score_gemma":0.00061126036,"threshold_uncertainty_score":0.999841},"labels":[],"label_agreement":null},{"id":"W3164065928","doi":"10.1002/psp4.12647","title":"Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Grifols; Mitsubishi Tanabe Pharma Corporation; CSL Behring; Baxalta; Argenx; European Commission; TG Therapeutics; Sanofi","keywords":"Chronic inflammatory demyelinating polyneuropathy; Dosing; Medicine; Antibody; Placebo; Polyradiculoneuropathy; Immunoglobulin E; Immunology; Population; Internal medicine; Polyneuropathy; Pharmacodynamics; Pharmacokinetics; Immunoglobulin G; Gastroenterology; Guillain-Barre syndrome; Pathology","score_opus":0.03899096057079242,"score_gpt":0.38571714529331225,"score_spread":0.3467261847225198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164065928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666854,0.020888621,0.00095932663,0.00085413427,0.008196197,0.0016027113,0.00005073659,0.000322537,0.0004403382],"genre_scores_gemma":[0.9878021,0.0037933397,0.00023703728,0.005668225,0.0014230255,0.00016147924,0.000075003714,0.00014209826,0.0006977114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906291,0.0019095937,0.0030773599,0.0016124235,0.0010876276,0.0016838906],"domain_scores_gemma":[0.99444735,0.0023406178,0.0007088685,0.0007361976,0.00072882377,0.001038148],"candidate_categories":["metaepi_narrow","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0029962475,0.0008085855,0.0026152215,0.006913872,0.00027126243,0.00014372458,0.0007524558,0.00039179792,0.0006150053],"category_scores_gemma":[0.0016136237,0.00081450783,0.0011491302,0.025881257,0.00014282479,0.00026721312,0.00068025547,0.002149274,0.0002020598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007024848,0.001859162,0.88127905,0.000580156,0.0029534774,0.0044005187,0.00025624275,0.018477412,0.07138296,0.000021081047,0.0018238242,0.016263653],"study_design_scores_gemma":[0.042934623,0.0025510306,0.8129637,0.00026712814,0.008025088,0.00043676732,0.00061070337,0.03263402,0.007933349,0.0000059053104,0.08938644,0.0022512502],"about_ca_topic_score_codex":0.00008664877,"about_ca_topic_score_gemma":0.000019629893,"teacher_disagreement_score":0.08756261,"about_ca_system_score_codex":0.0010853995,"about_ca_system_score_gemma":0.0010114103,"threshold_uncertainty_score":0.9994306},"labels":[],"label_agreement":null},{"id":"W3195626778","doi":"10.1002/psp4.12683","title":"Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Oak Foundation; National Science Foundation","keywords":"Medicine; Busulfan; Hematopoietic stem cell transplantation; Dosing; Pharmacokinetics; Population; Transplantation; Internal medicine; NONMEM; Oncology","score_opus":0.0286474273532771,"score_gpt":0.31781788589748167,"score_spread":0.2891704585442046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195626778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864256,0.0040844516,0.0016965017,0.00010988969,0.0034902028,0.0032162361,0.0003121403,0.00011866806,0.0005463104],"genre_scores_gemma":[0.9951417,0.0028451106,0.00041595456,0.0001266118,0.0005326602,0.0001615409,0.00052525534,0.00009616613,0.000155032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99305385,0.0012461727,0.0027763161,0.0011194256,0.0011183016,0.00068593357],"domain_scores_gemma":[0.9958784,0.0018871921,0.0008612406,0.00045649288,0.00053956785,0.00037710398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013261612,0.0005407415,0.0013500993,0.0020237602,0.00010586122,0.000053391053,0.0003166177,0.00026945613,0.0002241551],"category_scores_gemma":[0.00005174452,0.00056601944,0.00020953867,0.0043016947,0.00004753618,0.000245657,0.000066446286,0.0006996021,0.0000533405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007382787,0.012093307,0.38446343,0.009048325,0.00065678096,0.0069954055,0.027185932,0.00835581,0.5359587,0.000007780096,0.00058462674,0.0072670835],"study_design_scores_gemma":[0.09943411,0.0011525315,0.40384918,0.00089427276,0.008032853,0.0008953736,0.004669668,0.019729035,0.45967188,0.000011831332,0.0003219963,0.0013372512],"about_ca_topic_score_codex":0.00040957992,"about_ca_topic_score_gemma":0.000012442893,"teacher_disagreement_score":0.09205132,"about_ca_system_score_codex":0.0003577052,"about_ca_system_score_gemma":0.00024189588,"threshold_uncertainty_score":0.99967915},"labels":[],"label_agreement":null},{"id":"W4220832872","doi":"10.1002/psp4.12775","title":"Trapezoid bioequivalence: A rational bioavailability evaluation approach on account of the pharmaceutical‐driven balance of population average and variability","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Bioequivalence; Context (archaeology); Bioavailability; Population; Econometrics; Statistics; Mathematics; Variance (accounting); Weighting; Pharmacology; Medicine; Economics; Accounting; Geography","score_opus":0.44227961583645825,"score_gpt":0.543427230074723,"score_spread":0.1011476142382648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220832872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95892316,0.0006146722,0.022738557,0.0005746766,0.007180072,0.007167834,0.0016835488,0.000089780355,0.001027719],"genre_scores_gemma":[0.98798573,0.00007499387,0.010677965,0.00025702425,0.00024890443,0.0006704119,0.000020008487,0.000033331347,0.000031604006],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98374546,0.01100747,0.0021241945,0.0007974243,0.001923745,0.00040170443],"domain_scores_gemma":[0.96555465,0.031615607,0.0014856992,0.0005643138,0.00061697495,0.00016275006],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022292502,0.00032105958,0.0010474423,0.0004672396,0.00030688464,0.000021123577,0.0007576815,0.00015836018,0.0011834988],"category_scores_gemma":[0.018358592,0.00026108016,0.00023667376,0.002576444,0.0005992409,0.0001130485,0.0004781204,0.0008482747,0.0000018851684],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071583693,0.02375311,0.24205992,0.015545433,0.0034241027,0.0000142505,0.0021861154,0.07203267,0.36491716,0.20976782,0.020674028,0.03846703],"study_design_scores_gemma":[0.014418288,0.00085465156,0.027949711,0.000079783444,0.0027527162,0.00005440696,0.00019353305,0.82212263,0.020276552,0.10810904,0.0022780448,0.0009106155],"about_ca_topic_score_codex":0.000033255023,"about_ca_topic_score_gemma":1.2021725e-7,"teacher_disagreement_score":0.75009,"about_ca_system_score_codex":0.00054498494,"about_ca_system_score_gemma":0.00020778648,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4220836697","doi":"10.1002/psp4.12773","title":"Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Anti-Doping Agency","funders":"World Anti-Doping Agency","keywords":"Salbutamol; Medicine; Urine; Inhalation; Anesthesia; Asthma; Pharmacokinetics; Dosing; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.33662412453639423,"score_gpt":0.4537262868446154,"score_spread":0.11710216230822118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220836697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014077364,0.978274,0.0036275531,0.00071282085,0.0010139152,0.005905546,0.0100508565,0.0001626792,0.00011185259],"genre_scores_gemma":[0.020453377,0.9691998,0.00029950027,0.0013751631,0.00048367045,0.00698447,0.0011066041,0.000023963694,0.000073470415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930384,0.0019813662,0.0020153846,0.0013920921,0.00054188556,0.001030867],"domain_scores_gemma":[0.97708696,0.01972913,0.0020633386,0.00019568676,0.0003374592,0.000587398],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002611584,0.0010152912,0.006377065,0.0010516921,0.00057129655,0.00012210224,0.0009082094,0.00047404744,0.0016381248],"category_scores_gemma":[0.00025581295,0.0004791393,0.003453018,0.007338493,0.00023344779,0.00016855895,0.00037254576,0.001047795,0.0000043256296],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005186991,0.0036641643,0.00007601232,0.02151536,0.4378811,0.00008275953,0.000038330716,0.018503375,0.028341748,0.0013223295,0.01853034,0.46952575],"study_design_scores_gemma":[0.00079493166,0.00027497028,0.0000044478825,0.000022535622,0.3276824,0.000020850257,0.0000044028184,0.07351933,0.000026060177,0.000017013783,0.5970847,0.00054834626],"about_ca_topic_score_codex":0.00003280675,"about_ca_topic_score_gemma":0.0000017580782,"teacher_disagreement_score":0.5785544,"about_ca_system_score_codex":0.00023775511,"about_ca_system_score_gemma":0.0002121526,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W4224228483","doi":"10.1002/psp4.12780","title":"Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Hemolysis; Medicine; Hemoglobin; Hemolytic anemia; Anemia; Sickle cell anemia; Drug; Internal medicine; Mechanism of action; Dosing; Pharmacology; Gastroenterology; Disease; Chemistry; Biochemistry","score_opus":0.03499161389658911,"score_gpt":0.3309906387624917,"score_spread":0.29599902486590257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224228483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321854,0.0018815942,0.0020647992,0.00016751273,0.0009004438,0.0014719858,0.00010073038,0.000040874187,0.00015352933],"genre_scores_gemma":[0.9980094,0.00023238431,0.00035877537,0.00033047,0.000025609532,0.00026427014,0.000056611832,0.000033324173,0.00068914494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694026,0.00036342198,0.0011887469,0.0004131644,0.0006475054,0.00044692695],"domain_scores_gemma":[0.9983347,0.0003365276,0.00047497705,0.00019230084,0.00020243369,0.0004590823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017498252,0.00026156727,0.00088120165,0.00412578,0.00015887986,0.000010276482,0.00020673014,0.000085604275,0.00035790532],"category_scores_gemma":[0.00007319677,0.00026575278,0.00016031323,0.004916741,0.000058400317,0.00009163917,0.00023963854,0.00039521686,0.000004322173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009601749,0.0018256722,0.014632537,0.0019926832,0.0017501866,0.00017847528,0.008543844,0.062225424,0.89334655,0.00004891494,0.00267805,0.0031759245],"study_design_scores_gemma":[0.035398617,0.0020957454,0.013584052,0.00012583072,0.009535325,0.000100814585,0.012974611,0.38234532,0.50819623,0.00001940179,0.034056388,0.0015676679],"about_ca_topic_score_codex":0.00006355575,"about_ca_topic_score_gemma":0.0000033045762,"teacher_disagreement_score":0.3851503,"about_ca_system_score_codex":0.000523763,"about_ca_system_score_gemma":0.00088627305,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W4225286977","doi":"10.1002/psp4.12793","title":"Use of <scp>physiologically‐based</scp> pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education","keywords":"Dosing; Methadone; Medicine; Fentanyl; Pharmacokinetics; Pharmacogenomics; Obesity; Opioid; Adverse effect; Pharmacology; Anesthesia; Internal medicine","score_opus":0.08443269079515993,"score_gpt":0.34989629578294806,"score_spread":0.26546360498778815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225286977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908331,0.0045285937,0.00068628695,0.00043591936,0.0007402799,0.0024704635,0.00014027384,0.0000416601,0.00012342713],"genre_scores_gemma":[0.9956072,0.0010089728,0.00050671195,0.0024381755,0.00011994872,0.0002102279,0.000015434985,0.00003972827,0.00005358],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9962433,0.0006574435,0.0010122312,0.0005411133,0.00088613125,0.0006597834],"domain_scores_gemma":[0.9968642,0.0015633041,0.00062796246,0.00027897174,0.0003094902,0.00035608953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013654093,0.00039020047,0.0010537677,0.0009841626,0.00035701678,0.000027722543,0.00047864093,0.00008775195,0.00009595909],"category_scores_gemma":[0.0003186523,0.0002829969,0.00015788058,0.0054786634,0.0002150042,0.0002180789,0.00083553244,0.0010815511,0.000002012104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013229669,0.0018548165,0.5270753,0.00096197263,0.0016038131,0.00005589726,0.0006857848,0.20265439,0.25661162,0.00007508793,0.0021253738,0.004973021],"study_design_scores_gemma":[0.02559172,0.003774268,0.26670027,0.00031558474,0.005993084,0.00063141005,0.0012249672,0.5173326,0.12098029,0.000039188086,0.05655133,0.0008652434],"about_ca_topic_score_codex":0.00037076735,"about_ca_topic_score_gemma":0.0000017196105,"teacher_disagreement_score":0.31467825,"about_ca_system_score_codex":0.00028477015,"about_ca_system_score_gemma":0.00017436547,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W4281786061","doi":"10.1002/psp4.12829","title":"Evaluation of covariate effects using forest plots and introduction to the <i>coveffectsplot</i> R package","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Forest ecology and management","field":"Environmental Science","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Covariate; R package; Computer science; Visualization; Statistics; Econometrics; Data mining; Mathematics; Machine learning","score_opus":0.03073177740404282,"score_gpt":0.30999481980871296,"score_spread":0.27926304240467015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281786061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820978,0.00094178325,0.0045984713,0.0008113526,0.007797331,0.003329347,0.000019070776,0.000048532704,0.0003562826],"genre_scores_gemma":[0.9976696,0.000041633295,0.000072967116,0.0008469389,0.00040596045,0.0008076879,0.0000088636,0.000027402484,0.00011894174],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99570304,0.0020567593,0.00039611282,0.00049327,0.0009468785,0.00040391364],"domain_scores_gemma":[0.998821,0.0004340842,0.00030176106,0.00025166644,0.00006515184,0.00012632261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007082101,0.00019999109,0.0003034642,0.0004407466,0.0005510052,0.000023215687,0.00041892656,0.00004854193,0.000780013],"category_scores_gemma":[0.0002090174,0.00017430176,0.0000543839,0.0023016795,0.00014137721,0.00016210154,0.00096373644,0.00029765838,0.00007405101],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015801104,0.00037808457,0.009726641,0.00016051567,0.00031810836,0.000019270927,0.00051056955,0.76742953,0.14100185,0.0007162019,0.07505006,0.0045311414],"study_design_scores_gemma":[0.011134496,0.0019546857,0.064816035,0.000018354578,0.0050643124,0.00026696708,0.00041358988,0.638627,0.030110037,0.0010034499,0.245536,0.0010551107],"about_ca_topic_score_codex":0.0002802403,"about_ca_topic_score_gemma":0.000014110283,"teacher_disagreement_score":0.17048593,"about_ca_system_score_codex":0.0007773645,"about_ca_system_score_gemma":0.0000370092,"threshold_uncertainty_score":0.8540595},"labels":[],"label_agreement":null},{"id":"W4288050569","doi":"10.1002/psp4.12852","title":"Hallmarks of neurodegenerative disease: A systems pharmacology perspective","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Neurodegeneration; Disease; Systems pharmacology; Neuroscience; Drug development; Huntington's disease; Identification (biology); Drug discovery; Medicine; Drug; Computational biology; Biology; Bioinformatics; Pharmacology; Pathology","score_opus":0.12867754276560453,"score_gpt":0.4523864801158535,"score_spread":0.32370893735024897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288050569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001435135,0.96826667,0.000035864286,0.00011767252,0.01264909,0.012227278,0.0037715388,0.00028085412,0.0025075164],"genre_scores_gemma":[0.008683918,0.97765094,0.000016868285,0.0002290131,0.0026072494,0.007877061,0.0014086197,0.00043315854,0.0010931905],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9853262,0.0051942565,0.002903075,0.0023775853,0.0022131167,0.001985817],"domain_scores_gemma":[0.9897252,0.0028867638,0.002438481,0.00097040803,0.0012669862,0.0027121957],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015585325,0.0018761483,0.007324191,0.0062104217,0.0005459502,0.00010074752,0.0014073272,0.00056757656,0.0042045666],"category_scores_gemma":[0.0003017956,0.0016527,0.0022417235,0.007122221,0.00063443667,0.00026690698,0.0010104679,0.002915114,0.00029716673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005543078,0.01965408,0.00046783683,0.22173828,0.32030413,0.033918027,0.0005589805,0.0007766717,0.00030450095,0.0017769809,0.30880186,0.08615558],"study_design_scores_gemma":[0.0065247235,0.0010068696,0.000010074146,0.0014522354,0.05091908,0.00091370416,0.0002474992,0.0011457078,0.00004174014,0.000004250272,0.936678,0.0010561338],"about_ca_topic_score_codex":0.00027681031,"about_ca_topic_score_gemma":3.138811e-7,"teacher_disagreement_score":0.62787616,"about_ca_system_score_codex":0.0036929504,"about_ca_system_score_gemma":0.0054874653,"threshold_uncertainty_score":0.9993983},"labels":[],"label_agreement":null},{"id":"W4302283304","doi":"10.1002/psp4.12868","title":"Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harmonization; Agency (philosophy); Drug development; Physiologically based pharmacokinetic modelling; Regulatory science; Medicine; Dosing; Risk analysis (engineering); Management science; Pharmacology; Drug; Business; Engineering; Pharmacokinetics","score_opus":0.22617426149743738,"score_gpt":0.5258151985447362,"score_spread":0.2996409370472989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302283304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.938973,0.040493757,0.0004498189,0.013256104,0.004091858,0.0016569614,0.00030971403,0.000120304445,0.00064846093],"genre_scores_gemma":[0.9697716,0.012357653,0.00003718715,0.016692681,0.000555559,0.00044775216,0.000025659529,0.000058886722,0.000052968466],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9901779,0.005717514,0.00092261366,0.0012252328,0.0010007924,0.00095592526],"domain_scores_gemma":[0.9826431,0.015528545,0.0005019046,0.0002150435,0.00018839764,0.000922955],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0061530694,0.0006066194,0.00086796423,0.0008402279,0.0013534443,0.00010466041,0.0006799856,0.0003501826,0.0019210504],"category_scores_gemma":[0.0013474552,0.0005237412,0.00009473195,0.0016560947,0.0007120535,0.00062196754,0.00095346465,0.0044917334,0.000029094384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0288972,0.010401172,0.10092847,0.0013887476,0.007965345,0.0031264138,0.03899713,0.39236718,0.118452944,0.034159563,0.019126525,0.2441893],"study_design_scores_gemma":[0.008057575,0.00033980858,0.0025667925,0.000032783388,0.00072432566,0.00011675215,0.002558407,0.89849067,0.000836509,0.00055456284,0.085120946,0.0006008592],"about_ca_topic_score_codex":0.00084450375,"about_ca_topic_score_gemma":0.000024691937,"teacher_disagreement_score":0.5061235,"about_ca_system_score_codex":0.00042824243,"about_ca_system_score_gemma":0.00025232366,"threshold_uncertainty_score":0.99994665},"labels":[],"label_agreement":null},{"id":"W4310082281","doi":"10.1002/psp4.12886","title":"Delineating gene–environment effects using virtual twins of patients treated with clozapine","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Covariate; Clozapine; Statistics; Virtualization; Gene–environment interaction; Schizophrenia (object-oriented programming); Computer science; Econometrics; Psychology; Genotype; Mathematics; Biology; Psychiatry; Genetics","score_opus":0.017129206263323732,"score_gpt":0.2800405349078978,"score_spread":0.2629113286445741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310082281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885476,0.0023115585,0.0068897367,0.000022782833,0.0010687596,0.0008752317,0.00021166464,0.00002004294,0.000052590556],"genre_scores_gemma":[0.99718446,0.00032295877,0.00088260655,0.0003576424,0.00032541412,0.00022965547,0.0004461781,0.000058779216,0.00019233888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969143,0.00091028935,0.00072566303,0.0005630356,0.00035451792,0.00053216796],"domain_scores_gemma":[0.9985354,0.0001731514,0.00068817905,0.0002565778,0.00018111248,0.00016556992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007458527,0.00030901158,0.0005487834,0.00045345715,0.00031960633,0.00000850498,0.00036766232,0.00012842477,0.000110724446],"category_scores_gemma":[0.00008473104,0.00030083692,0.00012730983,0.00084300904,0.00009970252,0.0000061934707,0.00041797425,0.00025710743,0.0000050525573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003029138,0.00062869926,0.3002255,0.00006629866,0.0006162356,0.000013612076,0.00005032202,0.13471623,0.5594981,0.0000060667057,0.0025962892,0.0012797933],"study_design_scores_gemma":[0.041743297,0.015359043,0.11211943,0.0000395492,0.0030143328,0.0002648917,0.0006746318,0.1436106,0.51118946,0.000007397678,0.16895466,0.0030227124],"about_ca_topic_score_codex":0.00008990869,"about_ca_topic_score_gemma":4.3924442e-7,"teacher_disagreement_score":0.18810607,"about_ca_system_score_codex":0.00023364495,"about_ca_system_score_gemma":0.000106197185,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W4311934119","doi":"10.1002/psp4.12907","title":"Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report","year":2022,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Bioequivalence; Session (web analytics); Regulatory science; Computer science; Food and drug administration; Management science; Pharmaceutical industry; Risk analysis (engineering); Medicine; Pharmacology; Pharmacokinetics; Engineering","score_opus":0.801231966031526,"score_gpt":0.6141261854069908,"score_spread":0.1871057806245352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311934119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084725575,0.83454734,0.13790391,0.000041817246,0.010971412,0.010760536,0.0033112175,0.00037721588,0.0012392842],"genre_scores_gemma":[0.003156987,0.9237322,0.06801426,0.00014105054,0.001137332,0.0032057327,0.00012947634,0.000278909,0.00020404717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9725128,0.01443871,0.0068507716,0.002908924,0.0019164945,0.0013722959],"domain_scores_gemma":[0.904436,0.087071,0.0056279874,0.0013764214,0.00050197204,0.000986629],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.022885162,0.0016193176,0.008375788,0.0025805961,0.00037479808,0.000099382916,0.0023746635,0.0008028851,0.0023941435],"category_scores_gemma":[0.025670607,0.0014188989,0.001318559,0.005094449,0.0006768975,0.00017592455,0.0021327517,0.0036037539,0.000014939046],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053661107,0.0030114632,0.000130781,0.07959385,0.0056610005,0.0012757588,0.00011440861,0.0021699308,0.000114175564,0.0009287789,0.014869336,0.89159393],"study_design_scores_gemma":[0.007173502,0.001531231,0.000014848017,0.0049744067,0.03469258,0.0005338221,0.00015949816,0.24597238,0.00014148344,0.011340761,0.6893357,0.004129807],"about_ca_topic_score_codex":0.0000368313,"about_ca_topic_score_gemma":2.348086e-7,"teacher_disagreement_score":0.8874641,"about_ca_system_score_codex":0.00067448686,"about_ca_system_score_gemma":0.0010789294,"threshold_uncertainty_score":0.9996554},"labels":[],"label_agreement":null},{"id":"W4312039560","doi":"10.1002/psp4.12908","title":"Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling","year":2022,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; University of Waterloo","keywords":"Physiologically based pharmacokinetic modelling; Cannabidiol; Pharmacokinetics; Pharmacology; Chemistry; Fluconazole; Itraconazole; CYP3A4; Cytochrome P450; Rifampicin; UGT2B7; In vitro; Enzyme; Medicine; Glucuronidation; Antifungal; Biochemistry; Microsome; Dermatology","score_opus":0.054367380134750794,"score_gpt":0.3995164767172026,"score_spread":0.3451490965824518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312039560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672301,0.004114234,0.0101021975,0.005731357,0.0027999515,0.008209229,0.0013981564,0.00021982887,0.00019495198],"genre_scores_gemma":[0.9828361,0.00010523606,0.00014472043,0.0027861362,0.00075125956,0.012247739,0.00026254676,0.00009106207,0.0007751618],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9946174,0.00079668895,0.0013231224,0.0010397575,0.0007786772,0.0014443658],"domain_scores_gemma":[0.9981234,0.00020031158,0.00023294883,0.00036154338,0.0005884161,0.0004933925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017388473,0.0004637711,0.0011413051,0.0024758133,0.00065364776,0.00005211992,0.0006096695,0.00017697146,0.00034740375],"category_scores_gemma":[0.0002864346,0.00049524714,0.00031646504,0.0054164585,0.000104427134,0.00016207814,0.0003136606,0.0015063327,0.000008761483],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025765442,0.0010534244,0.00040517602,0.0003761775,0.0000890804,0.00017502566,0.00024902305,0.31376684,0.661181,0.000034231805,0.019687507,0.00040598447],"study_design_scores_gemma":[0.027806262,0.0019910748,0.0011179568,0.00008469471,0.0002936776,0.00010994323,0.00045996375,0.7973799,0.06829747,0.000029330275,0.101683095,0.00074664],"about_ca_topic_score_codex":0.00049447565,"about_ca_topic_score_gemma":0.000006072423,"teacher_disagreement_score":0.5928835,"about_ca_system_score_codex":0.0022293823,"about_ca_system_score_gemma":0.00061599165,"threshold_uncertainty_score":0.9997499},"labels":[],"label_agreement":null},{"id":"W4318455086","doi":"10.1002/psp4.12931","title":"Establishing the suitability of <scp>model‐integrated</scp> evidence to demonstrate bioequivalence for <scp>long‐acting</scp> injectable and implantable drug products: Summary of workshop","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"U.S. Food and Drug Administration; Teva Pharmaceutical Industries","keywords":"Bioequivalence; Food and drug administration; Computer science; Management science; Medicine; Risk analysis (engineering); Engineering; Pharmacology; Pharmacokinetics","score_opus":0.6228652721554956,"score_gpt":0.5726171040619016,"score_spread":0.050248168093594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318455086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026109917,0.92714804,0.0396609,0.00007524246,0.009521468,0.015784452,0.004603561,0.00034524171,0.00025010778],"genre_scores_gemma":[0.00060273,0.9396607,0.052898932,0.00009749751,0.001245434,0.0028114924,0.000042698466,0.00037827075,0.0022622326],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9798191,0.0072261756,0.0070093684,0.0023987328,0.0014279324,0.0021186613],"domain_scores_gemma":[0.5155687,0.47573516,0.0048035933,0.0012681505,0.0019799292,0.00064452336],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.043119684,0.0014884347,0.007995106,0.002278781,0.0004124926,0.00030590748,0.003399685,0.0009513044,0.000014050982],"category_scores_gemma":[0.40691793,0.0011082871,0.0009032288,0.011981218,0.00087438704,0.0005928091,0.0016143163,0.0025546928,0.000018263901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014906372,0.0012711072,0.00038920162,0.45252624,0.0044491333,0.00006543638,0.0013336429,0.00046897528,0.00208589,0.0020391133,0.35492522,0.18029697],"study_design_scores_gemma":[0.0067603644,0.0015863958,0.000013754291,0.10259247,0.04862647,0.00050517777,0.004589998,0.014092607,0.018703924,0.029249286,0.77116525,0.0021143048],"about_ca_topic_score_codex":0.00018077022,"about_ca_topic_score_gemma":0.000007932867,"teacher_disagreement_score":0.46850896,"about_ca_system_score_codex":0.00059567305,"about_ca_system_score_gemma":0.0019055508,"threshold_uncertainty_score":0.9997865},"labels":[],"label_agreement":null},{"id":"W4380422510","doi":"10.1002/psp4.12980","title":"Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ethnic group; Mechanism (biology); Medicine; Drug; Markov chain Monte Carlo; Pharmacology; Statistics; Monte Carlo method","score_opus":0.4743222873254233,"score_gpt":0.5033028148323203,"score_spread":0.028980527506897003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007009965,0.9783113,0.0008276946,0.000075664786,0.0036595622,0.0034583204,0.0061842883,0.00018520355,0.00028799634],"genre_scores_gemma":[0.1449624,0.8521277,0.00009446688,0.00039571273,0.00014112171,0.0013870228,0.00018684995,0.0002261327,0.00047859928],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9849893,0.0059337737,0.0045873313,0.0019416964,0.00085371814,0.001694193],"domain_scores_gemma":[0.986736,0.0077919383,0.0034046408,0.00077270705,0.00055718113,0.0007375053],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007131407,0.0019099712,0.012916144,0.007562474,0.00021790981,0.0000511985,0.002192753,0.0018792788,0.00054154295],"category_scores_gemma":[0.00018615743,0.0016048325,0.0029667385,0.014861793,0.0010832367,0.00022398267,0.0006378259,0.003258466,0.000026351969],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016589471,0.004883758,0.00014397097,0.09686728,0.51753646,0.00011215173,0.0034531476,0.03459906,0.018524675,0.0038062134,0.005306211,0.31310815],"study_design_scores_gemma":[0.0055444506,0.0002405612,0.000026094927,0.0005440301,0.43328518,0.000013670156,0.00028538977,0.29919127,0.0049136844,0.00036559746,0.25327992,0.0023101675],"about_ca_topic_score_codex":0.00021734493,"about_ca_topic_score_gemma":0.000013961987,"teacher_disagreement_score":0.31079796,"about_ca_system_score_codex":0.00026031845,"about_ca_system_score_gemma":0.00075227796,"threshold_uncertainty_score":0.9994165},"labels":[],"label_agreement":null},{"id":"W4385514007","doi":"10.1002/psp4.13022","title":"<scp>SARS‐CoV</scp>‐2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy","year":2023,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Viral load; Viral replication; Clinical trial; Medicine; Monoclonal antibody; Immunology; Virology; Selection (genetic algorithm); Virus; Antibody; Computer science; Internal medicine; Artificial intelligence","score_opus":0.0988031557012112,"score_gpt":0.42769283617812526,"score_spread":0.328889680476914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898237,0.0021959536,0.004695759,0.00012908556,0.0007936018,0.0016667214,0.000026525437,0.00025440106,0.00041427498],"genre_scores_gemma":[0.9944274,0.0005882924,0.00015908688,0.0042621503,0.00021477236,0.00014832652,0.000010159224,0.00007752513,0.000112308015],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969722,0.00015552861,0.0007606817,0.00062068173,0.0006433216,0.00084756844],"domain_scores_gemma":[0.99844885,0.0006253174,0.00019374458,0.00018770441,0.0003936059,0.000150777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012978645,0.00037734234,0.00081630587,0.003668772,0.00023282603,0.00007034011,0.00025297492,0.00022510087,0.0000018342955],"category_scores_gemma":[0.0002573055,0.00036031258,0.00012117661,0.004993404,0.0001019116,0.0002840859,0.0002582826,0.00060398836,0.000042265467],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038909883,0.00020178195,0.0059862826,0.000585465,0.0003444573,0.000046616402,0.0009550429,0.004260543,0.97494566,0.000030147785,0.0017277672,0.010527139],"study_design_scores_gemma":[0.0060769445,0.00041972674,0.00037279195,0.00004759902,0.00014837769,0.00007510209,0.000136657,0.8361387,0.15049003,0.000017680617,0.005929828,0.00014652063],"about_ca_topic_score_codex":0.00010722203,"about_ca_topic_score_gemma":0.0000018241706,"teacher_disagreement_score":0.8318782,"about_ca_system_score_codex":0.00022503798,"about_ca_system_score_gemma":0.0002506979,"threshold_uncertainty_score":0.9998849},"labels":[],"label_agreement":null},{"id":"W4390405127","doi":"10.1002/psp4.13102","title":"Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling","year":2023,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; University of Utah; Brigham Young University","keywords":"Physiologically based pharmacokinetic modelling; Ontogeny; Pharmacokinetics; Furosemide; Biology; Transporter; Meropenem; Pharmacology; Internal medicine; Medicine; Endocrinology; Gene","score_opus":0.04037110607239169,"score_gpt":0.3314192358834291,"score_spread":0.2910481298110374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390405127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80255675,0.003288954,0.18459836,0.00035711445,0.004734009,0.003451313,0.00034050268,0.0004477181,0.0002252926],"genre_scores_gemma":[0.99431926,0.0012249878,0.0014381717,0.0001528899,0.0011303839,0.00066270167,0.00046638024,0.00010428588,0.0005009578],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965756,0.00008354918,0.0012591786,0.0005945045,0.00064091996,0.0008462359],"domain_scores_gemma":[0.99828315,0.00023742394,0.00038250565,0.00024293437,0.0004889337,0.00036506695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013059295,0.0003876463,0.00096486264,0.0024534666,0.0001555381,0.000018598077,0.00029694298,0.0002610267,0.00013148236],"category_scores_gemma":[0.000038665436,0.00035315778,0.00039226204,0.0036771253,0.00005113316,0.00016761644,0.000025745105,0.0003446131,0.00005019144],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038656543,0.001951689,0.010794185,0.018925782,0.0019182306,0.00056101463,0.0015509955,0.14102897,0.77620894,0.00047961046,0.025227368,0.01748755],"study_design_scores_gemma":[0.015351593,0.0007186974,0.0009603614,0.00017536106,0.004358327,0.00007591102,0.00027980734,0.85271716,0.119444996,0.0004346534,0.004718035,0.00076508295],"about_ca_topic_score_codex":0.000022958226,"about_ca_topic_score_gemma":0.0000010668041,"teacher_disagreement_score":0.7116882,"about_ca_system_score_codex":0.00013784014,"about_ca_system_score_gemma":0.00030296,"threshold_uncertainty_score":0.99989206},"labels":[],"label_agreement":null},{"id":"W4391053062","doi":"10.1002/psp4.13093","title":"Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Microfluidic and Capillary Electrophoresis Applications","field":"Engineering","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of British Columbia; Hotchkiss Brain Institute; BC Mental Health & Substance Use Services","funders":"Monash University","keywords":"Clozapine; Dosing; Schizophrenia (object-oriented programming); Pharmacokinetics; Fluvoxamine; Virtual patient; Virtualization; Drug; Medicine; Anesthesia; Pharmacology; Computer science; Internal medicine; Psychiatry; Fluoxetine","score_opus":0.01410371169017295,"score_gpt":0.2716500253713405,"score_spread":0.25754631368116754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391053062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91597754,0.05618033,0.02375771,0.000016319727,0.0011278209,0.0020892383,0.0003974276,0.00024752395,0.00020609901],"genre_scores_gemma":[0.9800598,0.018641144,0.00021124398,0.000020365685,0.00015037801,0.0005802566,0.00013703265,0.00008737412,0.00011243168],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980965,0.000047902664,0.0007336277,0.00036703676,0.0002649604,0.00048994884],"domain_scores_gemma":[0.9990316,0.0003971333,0.00009224062,0.00019244336,0.00014311362,0.0001434654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023394724,0.00033797487,0.00053234235,0.0014674218,0.000072193965,0.00004718484,0.0002570198,0.00013232544,0.000043313965],"category_scores_gemma":[0.000013257003,0.0002848358,0.00011359247,0.0022080487,0.000052220792,0.00019381855,0.000030446137,0.00019672407,0.000011856816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023748777,0.00062572845,0.00058235234,0.0013722269,0.0010046151,0.000012377115,0.00060526596,0.056154534,0.8620793,0.0016962917,0.056746665,0.016745718],"study_design_scores_gemma":[0.0187488,0.0018198804,0.00059607986,0.00026527824,0.0007697411,0.000009542052,0.00006640821,0.60999846,0.21600257,0.000047667585,0.15075114,0.00092441024],"about_ca_topic_score_codex":0.000013844582,"about_ca_topic_score_gemma":0.0000013304891,"teacher_disagreement_score":0.6460768,"about_ca_system_score_codex":0.0006878028,"about_ca_system_score_gemma":0.00018705745,"threshold_uncertainty_score":0.99996036},"labels":[],"label_agreement":null},{"id":"W4394853075","doi":"10.1002/psp4.13141","title":"Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated <scp>DLBCL</scp> from the <scp>POLARIX</scp> study","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Rituximab; Adverse effect; Pharmacokinetics; Oncology; Population; Cyclophosphamide; Dosing; Pharmacology; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.026281336400886365,"score_gpt":0.3321197062955578,"score_spread":0.30583836989467145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394853075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538441,0.039840046,0.000023589131,0.00007528499,0.0015439423,0.0041490234,0.00028632733,0.00015963732,0.000078079705],"genre_scores_gemma":[0.9972437,0.0012250013,0.000047329086,0.00026230203,0.0003263163,0.00035073998,0.00028580189,0.000108376145,0.0001504235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99439335,0.00155159,0.0013430659,0.0009834138,0.0009703661,0.0007582276],"domain_scores_gemma":[0.99169904,0.0065143206,0.0005217338,0.00044613087,0.00040518312,0.00041359622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011429422,0.0006894602,0.0013293561,0.0019273872,0.0001658867,0.00015277197,0.00035314835,0.00021034094,0.000031703563],"category_scores_gemma":[0.00055104017,0.00046574764,0.00018392927,0.0046217525,0.0001507571,0.00025835118,0.00019507424,0.00057011395,0.000025286012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055167335,0.004535275,0.97371954,0.00029484078,0.0031782845,0.00046515348,0.002537883,0.0003743781,0.008713637,0.000006494863,0.0036104023,0.0020124114],"study_design_scores_gemma":[0.028277047,0.0027345903,0.9485396,0.00025880287,0.004442752,0.000037306858,0.00090473035,0.0029874109,0.007242082,0.0000036855502,0.004453976,0.00011802102],"about_ca_topic_score_codex":0.0021888134,"about_ca_topic_score_gemma":0.000017883056,"teacher_disagreement_score":0.04339964,"about_ca_system_score_codex":0.0006777337,"about_ca_system_score_gemma":0.00027388657,"threshold_uncertainty_score":0.9997794},"labels":[],"label_agreement":null},{"id":"W4398254453","doi":"10.1002/psp4.13157","title":"Moving the needle for oncology dose optimization: A call for action","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck KGaA","keywords":"Call to action; Action (physics); Medical physics; Medicine; Business; Physics","score_opus":0.050752178952854936,"score_gpt":0.416172120841646,"score_spread":0.36541994188879107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398254453","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001072223,0.0054229484,0.9786109,0.0010667881,0.0087448135,0.0035538934,0.00023497603,0.00041093712,0.0008825712],"genre_scores_gemma":[0.92235434,0.0007148934,0.045019,0.0014350354,0.012381131,0.013156156,0.00024848647,0.00030126362,0.0043897163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979968,0.00018863274,0.0005662238,0.0005110293,0.00016439444,0.00057291175],"domain_scores_gemma":[0.99699545,0.0021598663,0.00024223787,0.00019520016,0.000273551,0.00013367727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008943577,0.00031169713,0.00044360495,0.0006641958,0.0003784374,0.00015035112,0.00044418586,0.00012897162,0.0003020584],"category_scores_gemma":[0.000022786315,0.00025016477,0.0002698071,0.0014435392,0.00009233802,0.00032540556,0.000063043175,0.00037992783,0.000006552748],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058059505,0.0006284517,0.00037905556,0.0011530977,0.0024646942,0.000015439791,0.0010949441,0.2332732,0.13405013,0.016747491,0.38853696,0.22107597],"study_design_scores_gemma":[0.0012698896,0.0001691409,0.0000013922241,0.000012711727,0.0002258879,0.0000116410665,0.00010483265,0.41799676,0.008489771,0.00015831598,0.57135314,0.00020651081],"about_ca_topic_score_codex":0.000043748267,"about_ca_topic_score_gemma":2.4317367e-7,"teacher_disagreement_score":0.93359184,"about_ca_system_score_codex":0.0004245115,"about_ca_system_score_gemma":0.00019994666,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W4399355745","doi":"10.1002/psp4.13167","title":"Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of <scp>CYP2C19</scp> genetic variation and obesity in the pediatric population","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Duke Clinical Research Institute; National Institute of Environmental Health Sciences; University of North Carolina at Chapel Hill; Pennsylvania State University; University of Louisville; University of Pennsylvania; Wichita Medical Research and Education Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Penn State College of Medicine; Children's Hospital of Philadelphia","keywords":"Dosing; Physiologically based pharmacokinetic modelling; CYP2C19; Pharmacokinetics; Medicine; Pantoprazole; Population; Obesity; Pharmacology; Pharmacodynamics; Internal medicine; Omeprazole; Environmental health; Metabolism","score_opus":0.029294055198621893,"score_gpt":0.3344661254760887,"score_spread":0.30517207027746684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399355745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851027,0.010460319,0.0013445888,0.00009071984,0.0007729137,0.0020320208,0.000041015952,0.00004755769,0.00010813917],"genre_scores_gemma":[0.99823356,0.00063045823,0.00018759113,0.00027024702,0.00036699473,0.00023490402,0.000027068156,0.000030344385,0.000018856188],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969712,0.0006818588,0.00083999644,0.00045945166,0.0006261686,0.0004213304],"domain_scores_gemma":[0.99801683,0.0011750528,0.00019446589,0.00022594305,0.00023483523,0.00015287724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013990093,0.00029143767,0.0005753854,0.0011301034,0.00009021516,0.000033946777,0.00029570507,0.000112503025,0.000026573907],"category_scores_gemma":[0.00017977518,0.0001780679,0.00013610456,0.0029307266,0.000047536545,0.00008852989,0.00008971975,0.00038547005,0.0000149078605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019283702,0.0016217764,0.58436644,0.0022340554,0.00062293897,0.00025841364,0.002335312,0.12347367,0.2768268,0.00012460865,0.0004121012,0.00753109],"study_design_scores_gemma":[0.0027561523,0.00049708446,0.32653394,0.00004749985,0.0017307774,0.000056626403,0.00010005858,0.6635096,0.0044642165,0.00013714733,0.00010072896,0.000066184526],"about_ca_topic_score_codex":0.00015496089,"about_ca_topic_score_gemma":3.5571531e-7,"teacher_disagreement_score":0.5400359,"about_ca_system_score_codex":0.0001212249,"about_ca_system_score_gemma":0.00010412801,"threshold_uncertainty_score":0.7261398},"labels":[],"label_agreement":null},{"id":"W4401818898","doi":"10.1002/psp4.13216","title":"Development and comparison of model‐integrated evidence approaches for bioequivalence studies with pharmacokinetic end points","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Bioequivalence; Resampling; Type I and type II errors; Nonparametric statistics; Statistics; Sample size determination; Computer science; Sampling (signal processing); Confidence interval; Mathematics; Bioavailability","score_opus":0.8675392696483202,"score_gpt":0.634633286820038,"score_spread":0.23290598282828223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401818898","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2531434,0.06372334,0.671591,0.0005775618,0.005254922,0.0047881994,0.0003447725,0.00042434642,0.00015250038],"genre_scores_gemma":[0.645086,0.0011904545,0.3523525,0.00007919749,0.00024221436,0.0007830543,0.0000035645792,0.000079159436,0.00018389555],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943681,0.0009588084,0.002220333,0.0010216404,0.00072984543,0.0007013051],"domain_scores_gemma":[0.93373936,0.06441307,0.00065408164,0.00026249248,0.0006181224,0.00031285267],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0065105762,0.00057641615,0.001881948,0.0010530947,0.00016113273,0.000081988226,0.00057852623,0.00019242059,0.00006347592],"category_scores_gemma":[0.008989189,0.00043154406,0.00014312676,0.0022133454,0.00066862255,0.00022924272,0.0002640433,0.0005893085,0.00000853325],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069816685,0.0046873987,0.0030104131,0.12328573,0.021231651,0.00032927966,0.015915733,0.009455176,0.21693973,0.13297832,0.083774745,0.38141015],"study_design_scores_gemma":[0.005083062,0.00089746324,0.000023957427,0.0023334308,0.004321479,0.000075498836,0.0013675579,0.7481447,0.21105431,0.016487798,0.00904633,0.0011644356],"about_ca_topic_score_codex":0.0000037134673,"about_ca_topic_score_gemma":6.003816e-7,"teacher_disagreement_score":0.7386895,"about_ca_system_score_codex":0.00027077142,"about_ca_system_score_gemma":0.0003482829,"threshold_uncertainty_score":0.9998136},"labels":[],"label_agreement":null},{"id":"W4402014457","doi":"10.1002/psp4.13217","title":"Evaluation of model‐integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Bioequivalence; Pharmacokinetics; Econometrics; Computer science; Medicine; Mathematics; Pharmacology","score_opus":0.9654321675280938,"score_gpt":0.7370173842571133,"score_spread":0.22841478327098053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402014457","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025507346,0.053001676,0.9078482,0.00016425474,0.008353648,0.0043524997,0.00033088928,0.00031379936,0.00012770035],"genre_scores_gemma":[0.43464065,0.001735502,0.56175864,0.0000869184,0.0005476857,0.0009944591,0.0000031677655,0.00012267173,0.000110306246],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9852685,0.0073872595,0.003129733,0.0013944234,0.0018546203,0.00096547673],"domain_scores_gemma":[0.8989143,0.09580293,0.0010765283,0.00052604364,0.003346732,0.000333463],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.059284918,0.00071114564,0.002075812,0.0019247971,0.00021380656,0.00011073437,0.0009651482,0.0003154045,0.00011035731],"category_scores_gemma":[0.061474834,0.00062230474,0.0005206335,0.0039556758,0.00050070137,0.0004879889,0.0003603425,0.0008069385,0.000006653985],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030917145,0.00041941318,0.0000144312335,0.00967948,0.0033198588,0.000012532406,0.00087273994,0.61460465,0.274982,0.0114804525,0.005448562,0.078856714],"study_design_scores_gemma":[0.0018533499,0.00010527823,3.6747e-7,0.0007007577,0.009394201,0.000021116412,0.00016358172,0.8007347,0.057380117,0.12907447,0.000105334424,0.00046674002],"about_ca_topic_score_codex":0.000009825695,"about_ca_topic_score_gemma":1.2936702e-7,"teacher_disagreement_score":0.40913332,"about_ca_system_score_codex":0.00116741,"about_ca_system_score_gemma":0.0010546454,"threshold_uncertainty_score":0.9996228},"labels":[],"label_agreement":null},{"id":"W4402647866","doi":"10.1002/psp4.13235","title":"Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Esophagitis; Gastric acid; Medicine; Gastroenterology; Reflux esophagitis; Internal medicine; Stomach; Reflux; Disease","score_opus":0.08904044853055816,"score_gpt":0.38189005289012495,"score_spread":0.2928496043595668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402647866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866159,0.008688962,0.0015769433,0.0004081842,0.0007664225,0.0011235119,0.00018110845,0.00012223405,0.0005167355],"genre_scores_gemma":[0.997377,0.000100640485,0.00031807687,0.00016774671,0.00033811576,0.00007855628,0.000026520987,0.000055285036,0.001538097],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978725,0.00021031938,0.00068290235,0.00040434167,0.0004146414,0.00041531358],"domain_scores_gemma":[0.99711496,0.0021036186,0.00018019788,0.00018809763,0.000136997,0.00027614096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065396004,0.0002795946,0.00065020204,0.00074489554,0.00017229446,0.00005816289,0.00017777918,0.00014605661,0.00008487936],"category_scores_gemma":[0.00024561663,0.0001985347,0.00017393926,0.001550753,0.00018688872,0.00015662453,0.00014204328,0.0005250373,0.00009317366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012626316,0.0006127565,0.843144,0.0072301854,0.0025354663,0.0006838755,0.0012236768,0.002244067,0.12620623,0.0035963997,0.010040687,0.002356363],"study_design_scores_gemma":[0.014212152,0.0009029131,0.10751067,0.0018696937,0.010672764,0.0012722559,0.00011471614,0.6848168,0.17339501,0.0039378917,0.0005441228,0.00075101934],"about_ca_topic_score_codex":0.000006092139,"about_ca_topic_score_gemma":2.0508018e-8,"teacher_disagreement_score":0.7356334,"about_ca_system_score_codex":0.00019029697,"about_ca_system_score_gemma":0.00014557007,"threshold_uncertainty_score":0.809601},"labels":[],"label_agreement":null},{"id":"W4404075406","doi":"10.1002/psp4.13256","title":"Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Probabilistic and Robust Engineering Design","field":"Decision Sciences","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Bayer","keywords":"Physiologically based pharmacokinetic modelling; Sobol sequence; Sensitivity (control systems); Parametric statistics; Computer science; Suite; Pharmacokinetics; Parametric model; Pharmacology; Mathematics; Statistics; Engineering; Medicine","score_opus":0.17897910999179253,"score_gpt":0.4432367166416438,"score_spread":0.2642576066498513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404075406","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14189225,0.024214728,0.78550434,0.0006402539,0.03469,0.0050580488,0.002979766,0.00093784597,0.004082752],"genre_scores_gemma":[0.9959001,0.0004217348,0.000580611,0.0007091756,0.00088921125,0.00048073856,0.000101483594,0.00008157408,0.0008353671],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98568076,0.004425308,0.003367591,0.0025199603,0.0024554858,0.0015508708],"domain_scores_gemma":[0.98341507,0.0118791135,0.0010767236,0.0009850163,0.0017499453,0.00089415035],"candidate_categories":["metaepi_narrow","bibliometrics","scholarly_communication","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013934023,0.0010182426,0.003338566,0.0061173863,0.00031202866,0.0011176439,0.004134812,0.00049899286,0.001296298],"category_scores_gemma":[0.0008099205,0.000810025,0.001026143,0.033583254,0.0005563614,0.0011482906,0.0013363275,0.00085838506,0.00022735751],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003075996,0.00054527423,0.0007116755,0.00038867717,0.00424135,0.00055686996,0.000071712006,0.8559806,0.05860334,0.0030484875,0.0735972,0.0019472239],"study_design_scores_gemma":[0.002184896,0.00021160502,0.000769687,0.00005762813,0.005927683,0.000076015036,0.00007100673,0.96494997,0.0012952823,0.00040724265,0.023236997,0.0008119771],"about_ca_topic_score_codex":0.0005425239,"about_ca_topic_score_gemma":0.0000038839144,"teacher_disagreement_score":0.85400784,"about_ca_system_score_codex":0.0008427555,"about_ca_system_score_gemma":0.0008103709,"threshold_uncertainty_score":0.9999193},"labels":[],"label_agreement":null},{"id":"W4404610816","doi":"10.1002/psp4.13280","title":"Clinical study design strategies to mitigate confounding effects of time‐dependent clearance on dose optimization of therapeutic antibodies","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Killam Trusts","keywords":"Confounding; Medicine; Sample size determination; Population; Clinical trial; Internal medicine; Statistics; Mathematics","score_opus":0.06467598173167563,"score_gpt":0.42622265070390564,"score_spread":0.36154666897223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404610816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7138231,0.063476175,0.17833138,0.0003868186,0.03381663,0.0084427465,0.0001624809,0.0004297005,0.001130976],"genre_scores_gemma":[0.99730897,0.0010741418,0.00046051785,0.0002505402,0.00015113373,0.0000817247,0.000006163032,0.000041603016,0.0006251896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99419403,0.003240381,0.001262763,0.00064236653,0.00017186007,0.0004885786],"domain_scores_gemma":[0.99377656,0.0052654897,0.00034152993,0.00024620388,0.00027656692,0.00009364139],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028796534,0.00036077594,0.0011323694,0.0011773206,0.00010685769,0.000056430737,0.00048485692,0.00031805536,0.00029780142],"category_scores_gemma":[0.00022161641,0.00029023198,0.00020241289,0.0019144495,0.00032771513,0.00013009786,0.00013169023,0.00061154924,0.00011393201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001491587,0.001876786,0.00090726116,0.001179943,0.0036881,0.00010471449,0.0005007328,0.029183304,0.94489944,0.00041438805,0.00423395,0.011519817],"study_design_scores_gemma":[0.010203342,0.012691462,0.003088096,0.0008404662,0.0043752263,0.00008233745,0.0009901149,0.039677676,0.91922474,0.000085974236,0.007532475,0.001208097],"about_ca_topic_score_codex":0.000022364,"about_ca_topic_score_gemma":1.8673921e-7,"teacher_disagreement_score":0.2834859,"about_ca_system_score_codex":0.000076524026,"about_ca_system_score_gemma":0.00015713218,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W4405368987","doi":"10.1002/psp4.13287","title":"Clinical modeling of motor function to predict treatment efficacy and enable in silico treatment comparisons in infantile‐onset Pompe disease","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Clinical trial; Medicine; Disease; Confounding; Biomarker; Physical medicine and rehabilitation; Randomized controlled trial; Comet; Internal medicine; Physical therapy; Biology","score_opus":0.08787990650333857,"score_gpt":0.4296761385240595,"score_spread":0.34179623202072096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96813905,0.02445454,0.00047199955,0.0005116284,0.0018734233,0.004071872,0.00017745899,0.00011131394,0.00018871603],"genre_scores_gemma":[0.9938179,0.0043711844,0.00005589925,0.00013774414,0.0003639603,0.0007211099,0.0000725728,0.000060394614,0.0003992205],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9959727,0.0006076489,0.0013439952,0.00087703444,0.00048226325,0.0007163381],"domain_scores_gemma":[0.99744767,0.0011586233,0.0001087224,0.00028640052,0.00015048515,0.00084808277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010028468,0.00040241383,0.0012021172,0.003530458,0.00006255448,0.000051481093,0.00017458279,0.00017594443,0.000129329],"category_scores_gemma":[0.00023048972,0.00034122798,0.00019753112,0.003515429,0.00010910337,0.00015023968,0.00012923675,0.00044751013,0.00004981183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01262227,0.0104928315,0.87995636,0.0022122178,0.0014505615,0.0021769197,0.0010098616,0.035661157,0.024891013,0.00004038116,0.005045779,0.024440655],"study_design_scores_gemma":[0.022109317,0.0050303903,0.057069615,0.0003956639,0.0010780762,0.00006005733,0.0002695937,0.88940567,0.00078010786,0.0000064262613,0.023395032,0.0004000411],"about_ca_topic_score_codex":0.0012314874,"about_ca_topic_score_gemma":0.000024403382,"teacher_disagreement_score":0.8537445,"about_ca_system_score_codex":0.001185259,"about_ca_system_score_gemma":0.0006015367,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W4408504822","doi":"10.1002/psp4.70017","title":"Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged &lt; 5 Years With Homozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Dosing; Pharmacokinetics; Population; Lipoprotein; Gastroenterology; Body weight; Internal medicine; Pediatrics; Cholesterol","score_opus":0.03740819570575227,"score_gpt":0.3463627957102121,"score_spread":0.30895460000445985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408504822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97508246,0.020429384,0.00057457935,0.00012757206,0.0005535372,0.0029114678,0.0000859966,0.00009825401,0.00013675915],"genre_scores_gemma":[0.99531776,0.0033610936,0.00032345724,0.00042844168,0.00020886427,0.0001467061,0.000056332017,0.000056738674,0.000100608515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996534,0.00047067244,0.0010488881,0.000716483,0.0006086162,0.00062133605],"domain_scores_gemma":[0.99845254,0.00025753642,0.00029595618,0.00037971121,0.00023799796,0.00037626718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010817139,0.00042431254,0.0016043321,0.0016678046,0.000100957164,0.000036714617,0.00025977514,0.00025865858,0.000012174499],"category_scores_gemma":[0.00007204695,0.0003906436,0.00013296788,0.0025348985,0.00028469483,0.000118445045,0.00021300667,0.0008996421,0.0000013739993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002862392,0.0023632005,0.8242208,0.0027414039,0.0027178912,0.0002605904,0.00094316574,0.006994361,0.116528764,0.000044522003,0.0034252044,0.0368977],"study_design_scores_gemma":[0.051218096,0.0009432277,0.8693805,0.00046980506,0.002967593,0.0005218791,0.0001703515,0.062751815,0.009646817,0.000004226508,0.0013746531,0.0005510581],"about_ca_topic_score_codex":0.00024030179,"about_ca_topic_score_gemma":0.000004630564,"teacher_disagreement_score":0.10688195,"about_ca_system_score_codex":0.0002233299,"about_ca_system_score_gemma":0.00031405487,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W4409148862","doi":"10.1002/psp4.70028","title":"Harnessing Open‐Source Solutions: Insights From the First Open Systems Pharmacology (<scp>OSP</scp>) Community Conference","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; European Commission; Vlaamse regering; National Institute of Child Health and Human Development; Fonds Wetenschappelijk Onderzoek","keywords":"Open source; Context (archaeology); Open source software; Engineering; Library science; Engineering management; Pharmacology; Computer science; Medicine; Software; Biology","score_opus":0.11820851000632661,"score_gpt":0.3964888850400766,"score_spread":0.27828037503375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56059366,0.20746785,0.037292447,0.019022627,0.06897651,0.028814776,0.00086833455,0.0014376647,0.07552609],"genre_scores_gemma":[0.9704289,0.0034343312,0.00007612724,0.015324219,0.0012044585,0.0022310235,0.000265007,0.00009487729,0.0069410675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99111146,0.003864864,0.0018662524,0.0010352577,0.00073669705,0.001385466],"domain_scores_gemma":[0.986777,0.008758688,0.00123625,0.0013085518,0.001088124,0.0008313832],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036618775,0.00080554007,0.0018940473,0.0013191266,0.0029981048,0.0009797865,0.0054924963,0.0005484283,0.00031574088],"category_scores_gemma":[0.0013245452,0.00064057234,0.00024427343,0.005308339,0.0007976149,0.0010323514,0.003669362,0.002991808,0.00027410156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043643077,0.0027003728,0.008738759,0.0013541798,0.0034997405,0.00017669024,0.003825353,0.000790027,0.05608597,0.002302388,0.9160717,0.004018392],"study_design_scores_gemma":[0.01690358,0.00026473592,0.0056506908,0.0015695541,0.002773877,0.00021468407,0.0037701258,0.019976094,0.010578917,0.00013108642,0.9377698,0.00039688087],"about_ca_topic_score_codex":0.005782529,"about_ca_topic_score_gemma":0.000039668117,"teacher_disagreement_score":0.4098352,"about_ca_system_score_codex":0.0009841963,"about_ca_system_score_gemma":0.0019166246,"threshold_uncertainty_score":0.99988824},"labels":[],"label_agreement":null},{"id":"W4410241330","doi":"10.1002/psp4.70033","title":"Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor‐Associated Macrophages and Microglia to Treat Glioblastoma","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Microglia; Nivolumab; CD8; Medicine; Glioblastoma; CD47; Clinical trial; Cancer research; Immune system; Tumor microenvironment; Immunotherapy; Oncology; Immunology; Internal medicine; Inflammation","score_opus":0.029323852242914863,"score_gpt":0.37808100198340033,"score_spread":0.3487571497404855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410241330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9324309,0.017621186,0.0005893111,0.0002656556,0.04580124,0.0025990787,0.0002799317,0.00017487921,0.00023777597],"genre_scores_gemma":[0.9907817,0.0016009139,0.00007822081,0.001276959,0.00075034605,0.00021397341,0.000055914996,0.00007300133,0.0051689474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9882897,0.0048621953,0.0041207424,0.0013278291,0.00019602143,0.0012035199],"domain_scores_gemma":[0.99275404,0.004417167,0.0014731111,0.00046177255,0.00067375257,0.00022016582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006845629,0.0006555431,0.0024106966,0.0017287822,0.00035598106,0.00005843778,0.0010706347,0.00087799894,0.0005694047],"category_scores_gemma":[0.0019842074,0.0006415534,0.0005723759,0.0026383416,0.0009793711,0.00013242757,0.00081799494,0.0016154535,0.00023075013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026359975,0.0015985301,0.0059564384,0.00021123722,0.001755536,0.00013072908,0.00010418554,0.00009641092,0.7984375,0.000055602686,0.15922257,0.006071285],"study_design_scores_gemma":[0.2498027,0.010129626,0.0052764616,0.0003506083,0.004323505,0.00013808037,0.00089205225,0.00037707743,0.61481386,0.00004058023,0.11200557,0.0018498967],"about_ca_topic_score_codex":0.000102443206,"about_ca_topic_score_gemma":7.274973e-7,"teacher_disagreement_score":0.22344272,"about_ca_system_score_codex":0.000282727,"about_ca_system_score_gemma":0.00042912192,"threshold_uncertainty_score":0.99960357},"labels":[],"label_agreement":null},{"id":"W4412512208","doi":"10.1002/psp4.70081","title":"Integrated Modeling of Digital‐Motor and Clinician‐Reported Outcomes Using Item Response Theory: Towards Powerful Trials for Rare Neurological Diseases","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"Else Kröner-Fresenius-Stiftung; ZonMw; Ministero della Salute; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Physical medicine and rehabilitation; Item response theory; Psychology; Medicine; Neuroscience; Computer science; Clinical psychology; Psychometrics","score_opus":0.2257825793792282,"score_gpt":0.44570045099671457,"score_spread":0.21991787161748638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412512208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96888876,0.002568101,0.016928464,0.00038970864,0.0051464895,0.00341782,0.0024093296,0.00019547071,0.000055867644],"genre_scores_gemma":[0.9970144,0.00021745758,0.00011550683,0.0017664445,0.0001545776,0.00025743837,0.000025735222,0.000066865476,0.00038154377],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9898677,0.005191716,0.0023942129,0.0013099832,0.00050657254,0.00072981225],"domain_scores_gemma":[0.9766832,0.020709101,0.001102853,0.00042488798,0.0006794843,0.00040047057],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003196481,0.00062174327,0.001919562,0.002145364,0.00027276782,0.00021829149,0.0007377539,0.00021264423,0.00006392294],"category_scores_gemma":[0.043528114,0.00050721836,0.0005416303,0.0028073401,0.00039055073,0.00029950417,0.00039330553,0.00036703947,0.0000035848755],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01475407,0.0011057839,0.023808036,0.0004836677,0.00050106866,0.00015065333,0.00007951408,0.008625016,0.9459038,0.000422696,0.0013583938,0.0028072954],"study_design_scores_gemma":[0.013755567,0.0011723505,0.0042387904,0.00010458457,0.0031785513,0.00007304273,0.00027006527,0.65105826,0.3203062,0.00085163146,0.003946498,0.0010444777],"about_ca_topic_score_codex":0.0000076060023,"about_ca_topic_score_gemma":7.676526e-8,"teacher_disagreement_score":0.6424332,"about_ca_system_score_codex":0.00010772394,"about_ca_system_score_gemma":0.0006240621,"threshold_uncertainty_score":0.9997379},"labels":[],"label_agreement":null},{"id":"W4412984454","doi":"10.1002/psp4.70082","title":"A Pharmacometrics‐Informed Trial Simulation Framework for Optimizing Study Designs for Disease‐Modifying Treatments in Rare Neurological Disorders","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"HORIZON EUROPE Framework Programme; Eberhard Karls Universität Tübingen; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Analysis of covariance; Clinical trial; Population; Randomized controlled trial; Clinical study design; Disease; Randomization; Sample size determination; Computer science; Causal inference; Resampling; Research design; Machine learning; Medicine; Artificial intelligence; Statistics; Mathematics; Surgery; Pathology","score_opus":0.1851698973901009,"score_gpt":0.4608491044763785,"score_spread":0.2756792070862776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412984454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80743814,0.001036983,0.1583632,0.00031760155,0.009210037,0.022900904,0.00040871112,0.00026102367,0.00006341388],"genre_scores_gemma":[0.9837576,0.00034768655,0.001063006,0.0018735299,0.0005058507,0.0121164005,0.000045007186,0.00010430427,0.0001865717],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.992782,0.0016449259,0.0016161766,0.0018448919,0.00070046895,0.0014115255],"domain_scores_gemma":[0.97918797,0.018907554,0.0006357818,0.00044441235,0.00028915197,0.000535128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010207628,0.00080957165,0.0011323709,0.004658946,0.00071189454,0.0002675271,0.0011413625,0.00022585221,0.00006131069],"category_scores_gemma":[0.0063987053,0.0008023015,0.00048006244,0.007820755,0.00015404959,0.0004163085,0.00029596573,0.00057053094,0.000010627532],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09883575,0.015766285,0.03390236,0.0014125875,0.0006373577,0.00013825674,0.00067680556,0.76420045,0.06604125,0.00091258774,0.0030325542,0.014443724],"study_design_scores_gemma":[0.20151187,0.0036323273,0.0028147495,0.000073955096,0.0020439848,0.0000025776123,0.00030787644,0.746272,0.035770684,0.0009657437,0.005259791,0.0013444357],"about_ca_topic_score_codex":0.00001023306,"about_ca_topic_score_gemma":0.000001019969,"teacher_disagreement_score":0.17631951,"about_ca_system_score_codex":0.00047551835,"about_ca_system_score_gemma":0.00047774796,"threshold_uncertainty_score":0.9994428},"labels":[],"label_agreement":null},{"id":"W4414476131","doi":"10.1002/psp4.70115","title":"An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Waterloo","funders":"Food and Drug Administration; U.S. Food and Drug Administration; U.S. Department of Health and Human Services","keywords":"Bioequivalence; Physiologically based pharmacokinetic modelling; In silico; IVIVC; Toolbox; Rework; Inference; In vivo; Benchmark (surveying); Repurposing","score_opus":0.7654397942060153,"score_gpt":0.6792413634340045,"score_spread":0.08619843077201073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414476131","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046763137,0.0006305427,0.92118645,0.0003431707,0.022628753,0.007926081,0.00015979771,0.00027576942,0.00008630741],"genre_scores_gemma":[0.33658051,0.0006352081,0.6571993,0.0014384523,0.0025610514,0.0011715012,0.0000046568302,0.000111646164,0.00029766012],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9860591,0.0072856527,0.0036042393,0.0015598368,0.0005141166,0.0009770242],"domain_scores_gemma":[0.80157846,0.19559832,0.00089270144,0.00071320694,0.00058325235,0.0006340679],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.027120441,0.00057642505,0.002322923,0.0009677821,0.00044506832,0.0004280152,0.00229975,0.0008425883,0.00015894609],"category_scores_gemma":[0.0862099,0.000544262,0.00025790918,0.0022871124,0.00043001026,0.00033187715,0.0008558065,0.001292904,0.000015311669],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12737642,0.007847829,0.00034727217,0.0018535012,0.003572741,0.000068466354,0.00020044025,0.006655118,0.005058579,0.65396535,0.04518026,0.14787403],"study_design_scores_gemma":[0.07448085,0.004461715,0.000005531042,0.0001790574,0.0022056445,0.000009285484,0.00013762145,0.46361473,0.0010647689,0.45038345,0.0027319728,0.0007253733],"about_ca_topic_score_codex":0.000031615094,"about_ca_topic_score_gemma":2.44596e-7,"teacher_disagreement_score":0.4569596,"about_ca_system_score_codex":0.00018288358,"about_ca_system_score_gemma":0.0003926244,"threshold_uncertainty_score":0.9997009},"labels":[],"label_agreement":null},{"id":"W4414478367","doi":"10.1002/psp4.70120","title":"Model‐Informed Drug Development of Subcutaneous Nivolumab: Comparison of Pharmacokinetic Analysis Methodologies Using Clinical Trial Simulation","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"NONMEM; Pharmacokinetics; Population; Clinical trial; Population pharmacokinetics; Drug development; Pooled analysis; Drug","score_opus":0.3510040612031019,"score_gpt":0.5559946688922948,"score_spread":0.20499060768919286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414478367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7907421,0.008989962,0.19077644,0.000054573684,0.00727304,0.0015112794,0.00008630272,0.00009869413,0.00046763272],"genre_scores_gemma":[0.9794142,0.00025245096,0.019247519,0.00015202358,0.00008778699,0.00004508814,0.000045314464,0.000024103952,0.00073148904],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9913592,0.0028279026,0.0041420213,0.00072359625,0.00023209341,0.0007152394],"domain_scores_gemma":[0.9889574,0.007945462,0.0018514612,0.00038594392,0.0007567645,0.000102940096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004864727,0.00048658362,0.0027483548,0.0032998596,0.00023272111,0.000020517504,0.0008665094,0.00063332636,0.00035622378],"category_scores_gemma":[0.000917044,0.00043652405,0.000754815,0.00583881,0.00063659117,0.00011409031,0.00039296647,0.00082860974,0.000008472332],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03526812,0.0027076285,0.010962241,0.0011915977,0.022109905,0.000012745894,0.0008388748,0.38888037,0.48464125,0.0001806603,0.005006286,0.048200306],"study_design_scores_gemma":[0.034440137,0.00041394978,0.00030222748,0.00005596535,0.01158928,0.0000069092794,0.00032746352,0.64785844,0.29500833,0.000040698058,0.009408907,0.00054766034],"about_ca_topic_score_codex":0.000046251545,"about_ca_topic_score_gemma":0.0000041015264,"teacher_disagreement_score":0.2589781,"about_ca_system_score_codex":0.00025611607,"about_ca_system_score_gemma":0.0007056079,"threshold_uncertainty_score":0.99980867},"labels":[],"label_agreement":null},{"id":"W4414743051","doi":"10.1002/psp4.70121","title":"Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Sanofi","keywords":"Dosing; Regimen; Pharmacokinetics; Pharmacodynamics; Population; Atopic dermatitis; Phases of clinical research","score_opus":0.025567964184274865,"score_gpt":0.3532375779191448,"score_spread":0.3276696137348699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414743051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511854,0.029113747,0.008032098,0.002261383,0.0048021404,0.0040409043,0.00015959196,0.0000948308,0.0003098825],"genre_scores_gemma":[0.99531937,0.0020931512,0.00005751487,0.0014458286,0.00021107438,0.0005657182,0.000054006938,0.000031877218,0.00022146481],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972473,0.00043108876,0.0010790139,0.00046035336,0.00030344207,0.00047884486],"domain_scores_gemma":[0.99795973,0.0010121602,0.00035358992,0.0002926786,0.00025859312,0.00012325506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007145102,0.0003112659,0.00067863916,0.0011179667,0.00032702097,0.00003191709,0.00034268145,0.00016534116,0.00003643286],"category_scores_gemma":[0.00018600617,0.00022553654,0.00019727377,0.0021664319,0.00019239324,0.0001974388,0.00014448728,0.00047683835,0.0000013904039],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049070907,0.006282993,0.40351996,0.01701717,0.0055259196,0.00020128334,0.0019272646,0.0609263,0.29613897,0.0018729761,0.06310533,0.13857475],"study_design_scores_gemma":[0.020516925,0.000066006614,0.031345274,0.00028193937,0.0022478208,0.00018341727,0.00016103627,0.9327818,0.0075186198,0.00016079853,0.0045530293,0.00018334547],"about_ca_topic_score_codex":0.0000937862,"about_ca_topic_score_gemma":0.0000017322827,"teacher_disagreement_score":0.8718555,"about_ca_system_score_codex":0.00022849369,"about_ca_system_score_gemma":0.00015819262,"threshold_uncertainty_score":0.9197113},"labels":[],"label_agreement":null},{"id":"W4416333858","doi":"10.1002/psp4.70131","title":"The Impact of <scp>QSP</scp> Modeling on the Design and Optimization of Gene Therapy Approaches","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Genome editing; Biodistribution; Systems pharmacology; Genetic enhancement; Translation (biology); Systems biology; Genome; Biomedicine","score_opus":0.07335593318135632,"score_gpt":0.32528171797899813,"score_spread":0.2519257847976418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.837321,0.019528342,0.14124092,0.00007468953,0.0005894979,0.00083166396,0.000021474973,0.000009100062,0.00038330816],"genre_scores_gemma":[0.9888711,0.010293832,0.00022497242,0.00013266121,0.0001267817,0.0001064879,0.000015328285,0.000018709907,0.0002101581],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982766,0.00052149175,0.00046927473,0.00030371326,0.0001507644,0.00027817333],"domain_scores_gemma":[0.9984785,0.00064782286,0.00027624852,0.00026705558,0.000274202,0.00005618988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011092735,0.00021986067,0.0002909571,0.00031029634,0.00016924468,0.000034464483,0.0004810146,0.00014028522,0.0000049054947],"category_scores_gemma":[0.00014680176,0.00012972987,0.00015054193,0.00075635937,0.00015143878,0.0000078530975,0.0000961537,0.00016508054,9.92545e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013848889,0.0000939238,0.0002815279,0.000023418355,0.0005244395,5.4407496e-7,0.000057879708,0.5726273,0.42045408,0.000048739075,0.0047254763,0.0010241425],"study_design_scores_gemma":[0.00088049495,0.00042473516,0.00004663749,0.0000125237575,0.000064423286,0.000005413218,0.00016183563,0.5035496,0.4942822,0.000016647024,0.0004982241,0.00005727983],"about_ca_topic_score_codex":0.00003747981,"about_ca_topic_score_gemma":1.2789953e-7,"teacher_disagreement_score":0.15155007,"about_ca_system_score_codex":0.00003109342,"about_ca_system_score_gemma":0.000146248,"threshold_uncertainty_score":0.52902305},"labels":[],"label_agreement":null}]}